<h2 id="introduction">Introduction</h2> <p>The quest for effective pharmaceuticals often begins with guiding principles that streamline the complex process of drug discovery. Established in 1997, the ...
<h2 id="introduction">Introduction</h2> <p>The quest for effective pharmaceuticals often begins with guiding principles that streamline the complex process of drug discovery. Established in 1997, the Lipinski Rule of Five provides a critical framework for assessing the viability of potential drug candidates, emphasizing key molecular characteristics that enhance their likelihood of success in clinical trials. However, as the landscape of medicinal chemistry evolves, the relevance and applicability of these criteria come into question, particularly when faced with increasingly complex compounds.</p> <p>How do researchers balance adherence to these foundational guidelines with the need for innovation in drug design? This critical inquiry underscores the ongoing dialogue in clinical research, prompting a reevaluation of established norms in the pursuit of groundbreaking therapies.</p> <h2 id="define-lipinskis-rule-of-five">Def…